Loading company
$1.62+5.9%Nov 13 close
Figures through September 30, 2025, from the 6-K filed March 18, 2026
Past performance
- 1W
- +11.7%
- 1M
- -26.3%
- 3M
- -80.7%
- 6M
- -84.7%
- 1Y
- -93.1%
$1.62+5.9%Nov 13 close
Figures through September 30, 2025, from the 6-K filed March 18, 2026
From the company’s own 6-K filing.
Cellyan Biotechnology Co., Ltd has no earnings call transcript available.
The quote and the company description come from the 6-K Cellyan Biotechnology Co., Ltd filed on March 18, 2026 with its results; the table is built from its quarterly reports. Read the release on EDGAR Share prices are split- and dividend-adjusted.